PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Politics
Sequestration: How Big a Hit for FDA, Research and Pharma?
The greatly feared federal budget sequestration mandate went into effect March 1, and, initially, the impact was fairly muted. The stock market soared, employment rose and government workers continued on their jobs. Federal agencies, including the Food and Drug Administration (FDA), launched initiatives to comply with the mandated 5% across-the-board cut in spending (in reality [...]
Posted in FDA, Legal, R&D, healthcare, leadership Also tagged Capitol Hill, CDC, NIH, sequestration, Sequestration Act, United States Congress, White House Leave a comment
Clayton Christensen on the Future of Pharma
A keynote speaker at the 9thAnnual SaS Health Care & Life Sciences Executive Conference on May 10, ‘disruptive’ author of The Innovator’s Dilemma and Harvard business professor Clayton Christensen sat down with PharmExec to discuss the future of the pharmaceutical industry, and what Mitt Romney could bring to the White House.
Posted in Biotech, Events, FDA, IP, People, R&D, Regulatory, Safety, Technology, Uncategorized, healthcare, leadership Also tagged business model, change, Clayton Christensen, commercial model, conference, FDA, health analytics, innovation, Mitt Romney, public policy, SaS, Strategy 1 Comment
Supreme Court Considers the Affordable Care Act
Posted in Corporate Responsibility, Legal, Regulatory, Strategy, healthcare Also tagged Democrats, generics, healthcare reform, Medicaid, Medicare, republican, Republicans, United States Supreme Court Leave a comment
PBMs to Super Committee: Take $100 Billion From Pharma
A trade group representing the largest pharmacy benefits managers (PBMs) has proposed a way to trim $100 billion in government costs for prescription drugs over 10 years. To the pharmaceutical industry, that trim might look more like a beheading.
Posted in Marketing, Regulatory, Strategy, healthcare, leadership, pricing Also tagged deficit, government, PCMA, PhRMA, Super Committee 2 Comments
Congress 'Tip Toes' Around Obamacare